{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T18:22:04Z","timestamp":1759602124943},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Deficiency in tuberin results in activation the mTOR pathway and leads to accumulation of cell matrix proteins. The mechanisms by which tuberin regulates fibrosis in kidney angiomyolipomas (AMLs) of tuberous sclerosis patients are not fully known.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Method<\/jats:title>\n            <jats:p>In the present study, we investigated the potential role of tuberin\/mTOR pathway in the regulation of cell fibrosis in AML cells and kidney tumor tissue from tuberous sclerosis complex (TSC) patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>AML cells treated with rapamycin shows a significant decrease in mRNA and protein expression as well as in promoter transcriptional activity of alpha-smooth muscle actin (\u03b1-SMA) compared to untreated cells. In addition, cells treated with rapamycin significantly decreased the protein expression of the transcription factor YY1. Rapamycin treatment also results in the redistribution of YY1 from the nucleus to cytoplasm in AML cells. Moreover, cells treated with rapamycin resulted in a significant reduce of binding of YY1 to the \u03b1SMA promoter element in nuclear extracts of AML cells. Kidney angiomyolipoma tissues from TSC patients showed lower levels of tuberin and higher levels of phospho-p70S6K that resulted in higher levels of mRNA and protein of \u03b1SMA expression compared to control kidney tissues. In addition, most of the \u03b1-SMA staining was identified in the smooth muscle cells of AML tissues. YY1 was also significantly increased in tumor tissue of AMLs compared to control kidney tissue suggesting that YY1 plays a major role in the regulation of \u03b1SMA.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>These data comprise the first report to provide one mechanism whereby rapamycin might inhibit the cell fibrosis in kidney tumor of TSC patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1476-4598-12-49","type":"journal-article","created":{"date-parts":[[2013,5,25]],"date-time":"2013-05-25T10:14:40Z","timestamp":1369476880000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Novel mechanism of regulation of fibrosis in kidney tumor with tuberous sclerosis"],"prefix":"10.1186","volume":"12","author":[{"given":"Sitai","family":"Liang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriela","family":"Cuevas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaza","family":"Tizani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiffanie","family":"Salas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baojie","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samy L","family":"Habib","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,5,25]]},"reference":[{"key":"1121_CR1","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/j.1749-6632.1991.tb37754.x","volume":"615","author":"JP Osborne","year":"1991","unstructured":"Osborne JP, Fryer A, Webb D: Epidemiology of tuberous sclerosis. Ann N Y Acad Sci. 1991, 615: 125-127. 10.1111\/j.1749-6632.1991.tb37754.x","journal-title":"Ann N Y Acad Sci"},{"key":"1121_CR2","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.1056\/NEJMra055323","volume":"355","author":"PB Crino","year":"2006","unstructured":"Crino PB, Nathanson KL, Henske EP: The tuberous sclerosis complex. N Engl J Med. 2006, 355: 1345-1356. 10.1056\/NEJMra055323","journal-title":"N Engl J Med"},{"key":"1121_CR3","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K","volume":"83","author":"T Al-Saleem","year":"1998","unstructured":"Al-Saleem T, Wessner LL, Scheithauer BW, Patterson K, Roach ES, Dreyer SJ, Fujikawa K, Bjornsson J, Bernstein J, Henske EP: Malignant tumors of the kidney, brain, and soft tissues in children and young adults with the tuberous sclerosis complex. Cancer. 1998, 83: 2208-2216. 10.1002\/(SICI)1097-0142(19981115)83:10<2208::AID-CNCR21>3.0.CO;2-K","journal-title":"Cancer"},{"key":"1121_CR4","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1054\/bjoc.2001.2072","volume":"85","author":"L Parry","year":"2001","unstructured":"Parry L, Maynard JH, Patel A, Clifford SC, Morrissey C, Maher ER, Cheadle JP, Sampson JR: Analysis of the TSC1 and TSC2 genes in sporadic renal cell carcinomas. Br J Cancer. 2001, 85: 1226-1230. 10.1054\/bjoc.2001.2072","journal-title":"Br J Cancer"},{"key":"1121_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/gcc.2870130411","volume":"13","author":"EP Henske","year":"1995","unstructured":"Henske EP, Neumann HP, Scheithauer BW, Herbst EW, Short MP: Loss of heterozygosity in the tuberous sclerosis (TSC2) region of chromosome band 16p13 occurs in sporadic as well as TSC-associated renal angiomyolipomas. Genes Chromosomes Canc. 1995, 13: 295-298. 10.1002\/gcc.2870130411.","journal-title":"Genes Chromosomes Canc"},{"key":"1121_CR6","doi-asserted-by":"publisher","first-page":"7475","DOI":"10.1038\/sj.onc.1209090","volume":"24","author":"A Astrinidis","year":"2005","unstructured":"Astrinidis A, Henske EP: Tuberous sclerosis complex: linking growth and energy signaling pathways with human disease. Oncogene. 2005, 24: 7475-7481. 10.1038\/sj.onc.1209090","journal-title":"Oncogene"},{"key":"1121_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/ijc.21542","volume":"118","author":"J Jozwiak","year":"2006","unstructured":"Jozwiak J: Hamartin and tuberin working together for tumor suppression. Int J Cancer. 2006, 118: 1-5. 10.1002\/ijc.21542","journal-title":"Int J Cancer"},{"key":"1121_CR8","doi-asserted-by":"publisher","first-page":"6085","DOI":"10.1073\/pnas.97.11.6085","volume":"97","author":"T Carsillo","year":"2000","unstructured":"Carsillo T, Astrinidis A, Henske EP: Mutations in the tuberous sclerosis complex gene TSC2 are a cause of sporadic pulmonary lymphangioleiomyomatosis. Proc Natl Acad Sci USA. 2000, 97: 6085-6090. 10.1073\/pnas.97.11.6085","journal-title":"Proc Natl Acad Sci USA"},{"key":"1121_CR9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-5347(17)43234-4","volume":"138","author":"TJ Stillwell","year":"1987","unstructured":"Stillwell TJ, Gomez MR, Kelalis PP: Renal lesions in tuberous sclerosis. J Urol. 1987, 138: 477-481.","journal-title":"J Urol"},{"key":"1121_CR10","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/S0022-5347(17)50082-8","volume":"132","author":"RA Shapiro","year":"1984","unstructured":"Shapiro RA, Skinner DG, Stanley P, Edelbrock HH: Renal tumors associated with tuberous sclerosis: the case for aggressive surgical management. J Urol. 1984, 132: 1170-1174.","journal-title":"J Urol"},{"key":"1121_CR11","doi-asserted-by":"publisher","first-page":"7965","DOI":"10.1128\/MCB.24.18.7965-7975.2004","volume":"24","author":"Y Li","year":"2004","unstructured":"Li Y, Inoki K, Guan KL: Biochemical and functional characterizations of small GTPase Rheb and TSC2 GAP activity. Mol Cell Biol. 2004, 24: 7965-7975. 10.1128\/MCB.24.18.7965-7975.2004","journal-title":"Mol Cell Biol"},{"key":"1121_CR12","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S1097-2765(02)00568-3","volume":"10","author":"BD Manning","year":"2002","unstructured":"Manning BD, Tee AR, Logsdon MN, Blenis J, Cantley LC: Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-kinase\/akt pathway. Mol Cell. 2002, 10: 151-162. 10.1016\/S1097-2765(02)00568-3","journal-title":"Mol Cell"},{"key":"1121_CR13","doi-asserted-by":"publisher","first-page":"35364","DOI":"10.1074\/jbc.M205838200","volume":"277","author":"HC Dan","year":"2002","unstructured":"Dan HC, Sun M, Yang L, Feldman RI, Sui XM, Ou CC, Nellist M, Yeung RS, Halley DJ, Nicosia SV, Pledger WJ, Cheng JQ: Phosphatidylinositol 3-kinase\/Akt pathway regulates tuberous sclerosis tumor suppressor complex by phosphorylation of tuberin. J Biol Chem. 2002, 277: 35364-35370. 10.1074\/jbc.M205838200","journal-title":"J Biol Chem"},{"key":"1121_CR14","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1038\/ncb839","volume":"4","author":"K Inoki","year":"2002","unstructured":"Inoki K, Li Y, Zhu T, Wu J, Guan KL: TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling. Nat Cell Biol. 2002, 4: 648-657. 10.1038\/ncb839","journal-title":"Nat Cell Biol"},{"key":"1121_CR15","doi-asserted-by":"publisher","first-page":"15629","DOI":"10.1073\/pnas.95.26.15629","volume":"95","author":"G Rennebeck","year":"1998","unstructured":"Rennebeck G, Kleymenova EV, Anderson R, Yeung RS, Artzt K, Walker CL: Loss of function of the tuberous sclerosis 2 tumor suppressor gene results in embryoni c lethality characterized by disrupted neuroepithelial growth and development. Proc Natl Acad Sci USA. 1998, 95: 15629-15634. 10.1073\/pnas.95.26.15629","journal-title":"Proc Natl Acad Sci USA"},{"key":"1121_CR16","first-page":"539","volume":"12","author":"TL Plank","year":"1999","unstructured":"Plank TL, Logginidou H, Klein-Szanto A, Henske EP: The expression of hamartin, the product of the TSC1 gene, in normal human tissues and in TSC1- and TSC2-linked angiomyolipomas. Mod Pathol. 1999, 12: 539-545.","journal-title":"Mod Pathol"},{"key":"1121_CR17","first-page":"1201","volume":"149","author":"J Bjornsson","year":"1996","unstructured":"Bjornsson J, Short MP, Kwiatkowski DJ, Henske EP: Tuberous sclerosis-associated renal cell carcinoma: clinical, pathological, and genetic features. Am J Pathol. 1996, 149: 1201-1208.","journal-title":"Am J Pathol"},{"key":"1121_CR18","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/modpathol.3800624","volume":"19","author":"VA Robb","year":"2006","unstructured":"Robb VA, Astrinidis A, Henske EP: Frequent hyperphosphorylation of ribosomal protein S6 in lymphangioleiomyomatosis-associated angiomyolipomas. Mod Pathol. 2006, 19: 839-4.","journal-title":"Mod Pathol"},{"key":"1121_CR19","doi-asserted-by":"publisher","first-page":"7106","DOI":"10.1158\/0008-5472.CAN-06-4798","volume":"67","author":"L Ma","year":"2007","unstructured":"Ma L, Teruya-Feldstein J, Bonner P, Bernardi R, Franz DN, Witte D, Cordon-Cardo C, Pandolfi PP: Identification of S664 TSC2 phosphorylation as a marker for extracellular signal-regulated kinase mediated mTOR activation in tuberous sclerosis and human cancer. Cancer Res. 2007, 67: 7106-7112. 10.1158\/0008-5472.CAN-06-4798","journal-title":"Cancer Res"},{"key":"1121_CR20","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1101\/gad.1110003","volume":"17","author":"K Inoki","year":"2003","unstructured":"Inoki K, Li Y, Xu T, Guan KL: Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003, 17: 1829-1834. 10.1101\/gad.1110003","journal-title":"Genes Dev"},{"key":"1121_CR21","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1164\/rccm.201002-0232OC","volume":"183","author":"X Lin","year":"2011","unstructured":"Lin X, Sime PJ, Xu H, Williams MA, LaRussa L, Georas SN, Guo J: Yin yang 1 is a novel regulator of pulmonary fibrosis. Am J Respir Crit Care Med. 2011, 183: 1689-1697. 10.1164\/rccm.201002-0232OC","journal-title":"Am J Respir Crit Care Med"},{"key":"1121_CR22","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/S1357-2725(01)00041-3","volume":"33","author":"SG Roy","year":"2001","unstructured":"Roy SG, Nozaki Y, Phan SH: Regulation of alpha-smooth muscle actin gene expression in myofibroblast differentiation from rat lung fibroblasts. Int J Biochem Cell Biol. 2001, 33: 723-734. 10.1016\/S1357-2725(01)00041-3","journal-title":"Int J Biochem Cell Biol"},{"key":"1121_CR23","doi-asserted-by":"publisher","first-page":"38665","DOI":"10.1074\/jbc.M009881200","volume":"276","author":"FB Riquet","year":"2001","unstructured":"Riquet FB, Tan L, Choy BK, Osaki M, Karsenty G, Osborne TF, Auron PE, Goldring MB: YY1 is a positive regulator of transcription of the Col1a1 gene. J Biol Chem. 2001, 276: 38665-38672. 10.1074\/jbc.M009881200","journal-title":"J Biol Chem"},{"key":"1121_CR24","doi-asserted-by":"publisher","first-page":"3787","DOI":"10.1093\/ndt\/gfq456","volume":"25","author":"C Peces","year":"2010","unstructured":"Peces C, Cuesta-L\u00f3pez E, P\u00e9rez-Due\u00f1as V, Vega-Cabrera C, Azor\u00edn S, Selgas R: Low-dose rapamycin reduces kidney volume angiomyolipomas and prevents the loss of renal function in a patient with tuberous sclerosis complex. Nephrol Dial Transplant. 2010, 25: 3787-3791. 10.1093\/ndt\/gfq456","journal-title":"Nephrol Dial Transplant"},{"key":"1121_CR25","doi-asserted-by":"publisher","first-page":"F281","DOI":"10.1152\/ajprenal.00370.2007","volume":"294","author":"SL Habib","year":"2008","unstructured":"Habib SL, Riley DJ, Mahimainathan L, Bhandari B: Tuberin regulates the DNA repair enzyme OGG1. Am J Physiol Renal Physiol. 2008, 294: F281-F289.","journal-title":"Am J Physiol Renal Physiol"},{"key":"1121_CR26","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1093\/carcin\/bgq189","volume":"31","author":"SL Habib","year":"2010","unstructured":"Habib SL, Bhandari BK, Sadek N: Novel mechanism of regulation of the DNA repair enzyme OGG1 in tuberin-deficient cells. Carcinogenesis. 2010, 31: 2022-2030. 10.1093\/carcin\/bgq189","journal-title":"Carcinogenesis"},{"key":"1121_CR27","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1093\/carcin\/24.3.573","volume":"24","author":"SL Habib","year":"2003","unstructured":"Habib SL, Phan MN, Patel SK, Li D, Monks TJ, Lau SS: Reduced constitutive 8-oxoguanine-DNA glycosylase expression and impaired induction following oxidative DNA damage in the tuberin deficient Eker rat. Carcinogenesis. 2003, 24: 573-582. 10.1093\/carcin\/24.3.573","journal-title":"Carcinogenesis"},{"key":"1121_CR28","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/0003-2697(76)90527-3","volume":"72","author":"MM Bradford","year":"1976","unstructured":"Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976, 72: 248-254. 10.1016\/0003-2697(76)90527-3","journal-title":"Anal Biochem"},{"key":"1121_CR29","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/1476-4598-7-10","volume":"7","author":"SL Habib","year":"2008","unstructured":"Habib SL, Simone S, Barnes JJ: Tuberin Haploinsufficiency is Associated with the Loss of OGG1 in Rat Kidney Tumors. Mol Cancer. 2008, 7: 10-14.","journal-title":"Mol Cancer"},{"key":"1121_CR30","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1681\/ASN.2012030285","volume":"23","author":"SL Habib","year":"2012","unstructured":"Habib SL, Yadav M, Tizani S, Bhandari B, Valente AJ: Tuberin inhibits production of the matrix protein fibronectin in diabetes. J Am Soc Nephrol. 2012, 23: 1652-1662. 10.1681\/ASN.2012030285","journal-title":"J Am Soc Nephrol"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1476-4598-12-49.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:44:38Z","timestamp":1630608278000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/1476-4598-12-49"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,25]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1121"],"URL":"https:\/\/doi.org\/10.1186\/1476-4598-12-49","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,25]]},"assertion":[{"value":"24 January 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"49"}}